Affiliation:
1. : Islamic Azad University Neyshabur Branch
2. Birjand University of Medical Sciences
3. Islamic Azad University Neyshabur Branch
4. Islamic Azad University Mashhad Branch
Abstract
Abstract
Background
The most typical malignancy among women worldwide is breast cancer. Estrogen receptor play a vital role in this cancer. One of the most known mechanisms that affect the activity of this receptor is its phosphorylation by protein kinase pathways. Studies have shown that hesperetin has an effect on intracellular kinase pathways.
Purpose
The aim of this study was to investigate the effect of hesperetin on the level of expression, phosphorylation and activity of estrogen receptor .
Study design and methods:
MCF-7 cells were cultured in RPMI 1640 phenol red free medium containing charcoal stripped FBS and treated with hesperetin. MTT method was used to evaluate cell survival. The level of ERα protein and its phosphorylated form (Ser118) was determined by western blot technique. Luciferase reporter vector was used to evaluate ERE activity.
Results
The results of this study indicated that hesperetin reduced the survival of MCF-7 cells in a dose dependent manner. The level of expression and phosphorylation (Ser118) of estrogen receptor indicated a significant increase and decrease in the groups treated with hesperetin, respectively. Hesperetin increased the activity of the estrogen receptor in the nonexistence of E2, while in the existence of E2 it caused a significant decrease in receptor activity.
Conclusion
Based on the results of this study, it can be concluded that hesperetin has a significant effect on estrogen receptor expression, phosphorylation and activity probably through protein kinase pathways.
Publisher
Research Square Platform LLC
Reference21 articles.
1. Venkatesh T, Thankachan S, Kabekkodu SP, Chakraborti S, Suresh PS (2021) Emerging patterns and implications of breast cancer epigenetics: an update of the current knowledge. (ed)^(eds) Epigenetics and Reproductive Health. Elsevier, pp 295–324
2. Hyperactivation of MAPK induces tamoxifen resistance in SPRED2-deficient ERα-positive breast cancer;Vafeiadou V;Cancers,2022
3. Gogos A, Sbisa AM, Sun J, Gibbons A, Udawela M, Dean B (2015) A role for estrogen in schizophrenia: clinical and preclinical findings. International journal of endocrinology 2015
4. Sommer S, Fuqua SA (2001) Estrogen receptor and breast cancer. (ed)^(eds) Seminars in cancer biology, Elsevier, pp. 339–352
5. Estrogen receptor phosphorylation;Lannigan DA;Steroids,2003